The relationship between arteriovenous fistula success and inflammation

Figures & data

Table 1. The demographic characteristics of groups.

Variables	Successful AVF (n = 311)	Unsuccessful AVF (n = 75)	p Value
Median age	54.35 ± 20.4	56.36 ± 15.6	0.492
Sex			0.562
Male	168 (54%)	45 (60%)
Female	143 (46%)	30 (40%)
Median weight (kg)	70 ± 5.4	72 ± 4.9	0.520
BMI (kg/m^2)	21.9 ± 4.6	22.6 ± 4.2	0.101
Diabetic nephropathy	134 (43%)	35 (46%)	0.121
Chronic glomerulonephritis	72 (23.2%)	12 (16%)	0.097
Hypertensive nephropathy	58 (18.7%)	18 (24%)	0.233
Chronic pyelonephritis	31 (9.9%)	6 (8%)	0.104
Obstructive nephropathy	16 (5.1%)	4 (5.3%)	0.088
COPD	77 (24.7%)	18 (24%)	0.309
Smoking	156 (50.1%)	41 (54.6%)	0.289
Median GFR	33 ± 17	38 ± 16	0.411
PAD	29 (9.3%)	8 (10.6%)	0.410
History of MI	14 (4.5%)	3 (4%)	0.250
BUN levels (mg/dL)	110 ± 33	118 ± 30	0.809
Creatinine levels (mg/dL)	4.1 ± 2.5	4.2 ± 2.6	0.597
Mean BP (mm Hg)	136 ± 37	131 ± 33	0.103

COPD, chronic obstructive pulmonary disease; BUN; blood urea nitrogen; GFR, glomerular filtration rate; BP: Blood pressure; PAD, Peripheral arterial disease; MI, Myocardial infarction.

Table 2. Between groups in fistula localization.

AVF opening site	Successful AVF(n = 311)	Unsuccessful AVF (n = 75)	p Value
Left radiocephalic	138 (44.4%)	27 (37%)	0.310
Left brachiocephalic	56 (18%)	18 (24%)	0.842
Right radiocephalic	77 (24.8)	17 (22.7%)	0.633
Right brachiocephalic	40 (12.9)	13 (17.3%)	0.421

Table 3. The factor affecting in terms of the fistula success.

	Successful AVF (n = 311)	Unsuccessful AVF (n = 75)	p-Value
Systolic blood pressure (mmHg)	124.5 ± 12	114.6 ± 14	<0.05
Diastolic blood pressure (mmHg)	76.8 ± 11	68.4 ± 8	<0.05
Total Cholesterol (mg/dL)	172.3 ± 44.9	183.5 ± 28.2	>0.05
HDL-cholesterol (mg/dL)	39.6 ± 11.8	42.8 ± 12.5	>0.05
LDL-cholesterol (mg/dL)	114.8 ± 28.3	118.7 ± 28.6	>0.05
Triglyceride (mg/dL)	153.8 ± 82.2	148.6 ± 74.8	>0.05
Total protein (g/dL)	7.33 ± 0.46	6.8 ± 1.02	>0.05
Albumin (g/dL)	3.96 ± 0.4	3.0 ± 0.8	<0.001
CRP (mg/dL)	4.6 ± 2.2	18.6 ± 4.3	<0.001
Fibrinogen (mg/dL)	348.9 ± 96.8	530.5 ± 172.4	<0.001

Notes: p-Values of <0.05 were considered significant. HDL, High-density lipoprotein; LDL, Low-density lipoprotein; CRP, C-Reactive protein.